Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale President and CEO sold 11,006 shares at $1.32 ($14,528)
  5. 4 Open-market buy Chief Financial Officer bought 45,237 shares at an average $1.32 ($59,716)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Chief Financial Officer bought 33,784 shares at $1.50 ($50,676)
  9. 4 Open-market sale Chief Scientific Officer sold 18,849 shares at $2.06 ($38,829)
  10. 4 Open-market sale General Counsel and Secretary sold 9,833 shares at $2.06 ($20,256)
  11. 4 Exercise or conversion Chief Financial Officer acquired 47,728 shares (option exercise)
  12. 4 Exercise or conversion VP & Corporate Controller acquired 6,061 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 14 · 269 filings